ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2476

Analysis of the Disease Activity and Functional Measures of Young Patients with Rheumatoid Arthritis Undergoing Total Joint Arthroplasty By Using the Database of Nation-Wide Observational Cohort

Kimio Masuda1, Tatsuou Ikenaka1, Toshihiro Matsui2 and Shigeto Tohma3, 1Department of Rehabilitation Medicine, National Hospital Organization Sagamihara Hospital, Sagamihara, Japan, 2Department of Rheumatology, National Hospital Organization Sagamihara Hospital, Sagamihara, Japan, 3National Hospital Organization Tokyo National Hospital, Kiyose, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Arthroplasty, Outcome measures, Rheumatoid arthritis (RA), surgery and young adults

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster III: Complications of Therapy, Outcomes, and Measures

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The aim of this study was to investigate the impact of total joint arthroplasty (TJA) on the disease activity and functional measures of young patients with rheumatoid arthritis (RA).

Methods: Totally 15341 RA patients were registered with NinJa (National Database of Rheumatic Diseases by iR-net in Japan), which is one of the biggest database of nation-wide observational cohort in JAPAN. The data including HAQ-DI (Health Assessment Questionnaire Disability Index), EQ-5D (EuroQol 5 Dimension) as well as SDAI(Simplified disease activity index), CDAI (Clinical Disease Activity Index) and DAS28 (Disease Activity Score 28) was analyzed.

Results: Among them, 1960 patients were under 50 years old, 85 with TJA (group T) and 1875 without TJA (group C). The age at onset of RA was 25.1 years old in group T and 33.5 years old in group C. Methotrexate was used in 54 patients (63.5%) in group T and in 1333 patients (71.5%) in group C, and biologics was used in 49 patients (57.6%) in group T and in 639 patients (34.1%) in group C. In group T, HAQ-DI was 0.97, EQ-5D was 0.68, DAS28 was 2.98,SDAI was 9.06,and CDAI was 8.59. Each score was inferior to that in group C (0.27,0.81,2.51,6.17,5.78, respectively). Moreover, in comparison with 11126 patients over 50 years old without TJA (group O), each score in group T was also inferior to that of group O (0.55,0.77,2.90,6.82,6.28, respectively).

Conclusion: The data demonstrated that patients of group T showed higher disease activity and lower functional ability as well as lower QOL status despite functional reconstruction with TJA, suggesting that the more aggressive therapeutic strategy should be needed for better functional outcome in young patients undergoing TJA.


Disclosure: K. Masuda, None; T. Ikenaka, None; T. Matsui, None; S. Tohma, None.

To cite this abstract in AMA style:

Masuda K, Ikenaka T, Matsui T, Tohma S. Analysis of the Disease Activity and Functional Measures of Young Patients with Rheumatoid Arthritis Undergoing Total Joint Arthroplasty By Using the Database of Nation-Wide Observational Cohort [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/analysis-of-the-disease-activity-and-functional-measures-of-young-patients-with-rheumatoid-arthritis-undergoing-total-joint-arthroplasty-by-using-the-database-of-nation-wide-observational-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/analysis-of-the-disease-activity-and-functional-measures-of-young-patients-with-rheumatoid-arthritis-undergoing-total-joint-arthroplasty-by-using-the-database-of-nation-wide-observational-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology